Lignocaine can be used in all except –
Now, the question is asking where it's not used. The options aren't provided, but the correct answer is probably a situation where lignocaine is contraindicated. Let's think about contraindications. Lignocaine is not used in certain arrhythmias. For example, it's a class IB antiarrhythmic, so it's used for ventricular arrhythmias, but not for atrial issues. Also, it's not used in patients with a known allergy to amide-type local anesthetics. Another point is its use in Wolff-Parkinson-White syndrome. Wait, no, that's more related to other antiarrhythmics like procainamide. Also, lignocaine isn't used in treating atrial fibrillation or flutter because it doesn't affect the AV node much. So, maybe an option like atrial fibrillation would be the right answer.
Wait, but the question is about where it's not used. So the answer is likely atrial fibrillation. Let me double-check. Lignocaine is used for ventricular arrhythmias, so in atrial conditions, it's not effective. Also, in local anesthesia, it's not used in certain areas where vasoconstrictors are contraindicated, but the question is about all except. Maybe the options include something like treating atrial fibrillation, which would be incorrect. So the correct answer is an option where lignocaine isn't used, like in atrial arrhythmias. Therefore, the explanation should highlight that lignocaine is a class IB antiarrhythmic effective for ventricular arrhythmias, not for atrial, and its use in atrial conditions would be incorrect. The wrong options might include other uses where lignocaine is actually appropriate.
**Core Concept**
Lignocaine (lidocaine) is a class I antiarrhythmic drug and local anesthetic. It blocks sodium channels, reducing cardiac automaticity and treating ventricular arrhythmias. Key contraindications include hypersensitivity and use in supraventricular arrhythmias due to limited AV nodal effects.
**Why the Correct Answer is Right**
Lignocaine is ineffective for **atrial fibrillation** because it doesnβt significantly slow AV nodal conduction. Itβs used for ventricular arrhythmias (e.g., ventricular tachycardia) and as a local anesthetic. Since atrial fibrillation requires drugs targeting atrial or AV nodal conduction (e.g., beta-blockers, calcium channel blockers), lignocaine exclusion in this context is correct.
**Why Each Wrong Option is Incorrect**
**Option A:** *Intravenous local anesthetic for nerve blocks* β Correct use; lignocaine is administered intravenously for nerve blocks.
**Option B:** *Treatment of ventricular tachycardia* β Correct use